מרצה: Meir Goldsmith, Michael D. Shapiro, Hagai Tavori and Kevin Jon Williams
תאריך: 24/06/2021 - 26/06/2021
Chairpersons: Eran Leitersdorf | Barak Zafrir
RNA-based treatments: an innovative platform for advanced therapeutic opportunities
Meir Goldsmith
Tel-Aviv University, Israel
Therapeutic approaches to antagonizing PCSK9
Michael D. Shapiro
Wake Forest University School of Medicine, USA
Lp(a) reduction by PCSK9 inhibitors – what do we (don’t) know?
Hagai Tavori
Sanofi Aventis, Israel
Eradicating atherosclerotic cardiovascular events by altering the trajectory of subclinical disease
Kevin Jon Williams
Temple University School of Medicine, USA
